FIELD: medicine, veterinary science, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition containing ondansetron and benzamide in the amount from 1:4 to 1:200. The composition elicits antiemetic activity and prevents toxic effect of cytostatics and other medicinal agents used in treatment of cancer patients. The composition elicits the improved antiemetic properties as compared with ondansetron and benzamide taken separately. EFFECT: improved medicinal properties of composition. 3 cl, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIEMETIC AGENT BENZAMIDE | 2002 |
|
RU2205009C1 |
PHARMACEUTICAL COMPOSITION COMPRISING ONDANSETRON, METHACINE AND BENZAMIDE | 2003 |
|
RU2234315C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ONDANSETRON AND METHACINE | 2001 |
|
RU2185825C1 |
AGENT DIMINISHING TOXICITY OF ANTI-TUMOR PREPARATIONS | 2003 |
|
RU2236848C1 |
PHARMACEUTICAL COMPOSITION FOR REDUCTION OF PRIMARY RADIATION RESPONSE AND EARLY TRANSIENT INCAPABILITY | 2012 |
|
RU2509557C1 |
MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
COMBINED COMPOSITION OF SUBSTANCES WITH COMPLEX PHARMACOLOGICAL ACTIVITY | 2014 |
|
RU2622991C2 |
METHOD OF PRODUCING 4-AMINO-2-(2-BUTANONE-3-YL)-OXY-5-CHLORO-N-/2-(DIETHYLAMINO) ETHYL/ BENZAMIDE OR ITS SALTS | 0 |
|
SU1517759A3 |
(R)-5-BROMO-N-ETHYL-4-METHYLHEXAHYDRO-1H-1,4-DIAZEPIN-6- YL)-2-METHOXY-6 METHYLAMINO-3-PYRIDINECARBOXAMIDE, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND ANTIEMETIC AGENT COMPRISING SAID COMPOUNDS, AND INTERMEDIATE COMPOUND THEREOF | 1996 |
|
RU2156248C2 |
METHOD OF PRODUCING SUBSTITUTED BENZAMIDES | 0 |
|
SU1398771A3 |
Authors
Dates
2004-05-20—Published
2003-03-21—Filed